20-13074496-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018327.4(SPTLC3):c.606G>T(p.Met202Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000559 in 1,609,338 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018327.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTLC3 | NM_018327.4 | c.606G>T | p.Met202Ile | missense_variant, splice_region_variant | 4/12 | ENST00000399002.7 | NP_060797.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTLC3 | ENST00000399002.7 | c.606G>T | p.Met202Ile | missense_variant, splice_region_variant | 4/12 | 1 | NM_018327.4 | ENSP00000381968.2 | ||
SPTLC3 | ENST00000450297.1 | c.525G>T | p.Met175Ile | missense_variant, splice_region_variant | 4/5 | 3 | ENSP00000409125.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246308Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133490
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1457170Hom.: 0 Cov.: 31 AF XY: 0.00000690 AC XY: 5AN XY: 724412
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.606G>T (p.M202I) alteration is located in exon 4 (coding exon 4) of the SPTLC3 gene. This alteration results from a G to T substitution at nucleotide position 606, causing the methionine (M) at amino acid position 202 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at